Novartis chairman claims Alcon worth $20-$30B

Note: This section contains information in English only.
Source: Dukascopy Bank SA
The chairman of the Swiss drugmaker Novartis anticipates Alcon to be valued between $20B and $30B after the new ophthalmic devices unit is rolled out to shareholders in the following year.
Back to articles

Actual Topics

Sat, 30 Jun 2018 16:38:07 GMT

Mexicans reject presidential vote with bulldozers and blockades

The leaders representing indigenous Mexicans people have promised to disrupt voting in their communities to protest failed system.

Sat, 30 Jun 2018 14:48:47 GMT

Iran leaders try to find ways to protect economy against US sanctions

Iran is looking for solutions to maintain oil export at the same rate and counter the US economic sanctions, state news agency IRNA disclosed on Saturday.

Subscribe to "Fundamental Analysis" feed

Subscribe
Per scoprire di più sulla piattaforma di Dukascopy Bank per Forex/CFD, sul SWFX ed altre informazioni relative al trading,
la preghiamo di contattarci o richiedere di essere contattato (callback request)
For further information regarding potential cooperation,
please call us or make callback request.
To learn more about Dukascopy Bank Binary Options / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
Per scoprire di più sulla piattaforma di Dukascopy Bank per Forex/CFD, sul SWFX ed altre informazioni relative al trading,
la preghiamo di contattarci o richiedere di essere contattato (callback request).
To learn more about Crypto Trading / CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Business Introducer and other trading related information,
please call us or make callback request.
For further information regarding potential cooperation,
please call us or make callback request.